Literature DB >> 29751329

Determination of metals and pharmaceutical compounds released in hospital wastewater from Toluca, Mexico, and evaluation of their toxic impact.

Itzayana Pérez-Alvarez1, Hariz Islas-Flores2, Leobardo Manuel Gómez-Oliván3, Damià Barceló4, Miren López De Alda4, Sandra Pérez Solsona4, Livier Sánchez-Aceves1, Nely SanJuan-Reyes1, Marcela Galar-Martínez5.   

Abstract

Due to the activities inherent to medical care units, the hospital effluent released contains diverse contaminants such as tensoactives, disinfectants, metals, pharmaceutical products and chemical reagents, which are potentially toxic to the environment since they receive no treatment or are not effectively removed by such treatment before entering the drain. They are incorporated into municipal wastewater, eventually entering water bodies where they can have harmful effects on organisms and can result in ecological damage. To determine the toxicological risk induced by this type of eflluents, eight metals and 11 pharmaceuticals were quantified, in effluent from a hospital. Developmental effects, teratogenesis and oxidative stress induction were evaluated in two bioindicator species: Xenopus laevis and Lithobates catesbeianus. FETAX (frog embryo teratogenesis assay-Xenopus) was used to obtain the median lethal concentration (LC50), effective concentration inducing 50% malformation (EC50), teratogenic index (TI), minimum concentration to inhibit growth (MCIG), and the types of malformation induced. Twenty oocytes in midblastula transition were exposed to six concentrations of effluent (0.1, 0.3, 0.5, 0.7, 0.9, 1%) and negative and positive (6-aminonicotinamide) controls. After 96 h of exposure, diverse biomarkers of oxidative damage were evaluated: hydroperoxide content, lipid peroxidation, protein carbonyl content, and the antioxidant enzymes superoxide dismutase and catalase. TI was 3.8 in X. laevis and 4.0 in L. catesbeianus, both exceed the value in the FETAX protocol (1.2), indicating that this effluent is teratogenic to both species. Growth inhibition was induced as well as diverse malformation including microcephaly, cardiac and facial edema, eye malformations, and notochord, tail, fin and gut damage. Significant differences relative to the control group were observed in both species with all biomarkers. This hospital effluent contains contaminants which represents a toxic risk, since these substances are teratogenic to the bioindicators used. The mechanism of damage induction may be associated with oxidative stress.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FETAX; Hospital effluent; Lithobates catesbeianus; Metal; Pharmaceuticals; Xenopus laevis

Mesh:

Substances:

Year:  2018        PMID: 29751329     DOI: 10.1016/j.envpol.2018.04.116

Source DB:  PubMed          Journal:  Environ Pollut        ISSN: 0269-7491            Impact factor:   8.071


  4 in total

1.  Sensitivity of zebrafish (Danio rerio) embryos to hospital effluent compared to Daphnia magna and Aliivibrio fischeri.

Authors:  M Wittlerová; G Jírová; A Vlková; K Kejlová; M Malý; T Heinonen; Zdeňka Wittlingerová; M Zimová
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

Review 2.  Sample Preparation to Determine Pharmaceutical and Personal Care Products in an All-Water Matrix: Solid Phase Extraction.

Authors:  Daniele Sadutto; Yolanda Picó
Journal:  Molecules       Date:  2020-11-09       Impact factor: 4.411

Review 3.  A Review of the Presence of SARS-CoV-2 in Wastewater: Transmission Risks in Mexico.

Authors:  Mayerlin Sandoval Herazo; Graciela Nani; Florentina Zurita; Carlos Nakase; Sergio Zamora; Luis Carlos Sandoval Herazo; Erick Arturo Betanzo-Torres
Journal:  Int J Environ Res Public Health       Date:  2022-07-08       Impact factor: 4.614

4.  Gut microbiota dysbiosis involves in host non-alcoholic fatty liver disease upon pyrethroid pesticide exposure.

Authors:  Meng Li; Tingting Liu; Teng Yang; Jiaping Zhu; Yunqian Zhou; Mengcen Wang; Qiangwei Wang
Journal:  Environ Sci Ecotechnol       Date:  2022-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.